Proxy Votes Now

Home › Funds › Capital Group › Tax-Exempt Fund of California

Tax-Exempt Fund of California (EXCAX) proxy voting record 2025-2026

Fund family: Capital Group · Filed by AMERICAN FUNDS TAX EXEMPT SERIES II / CA (CIK 794389) · SEC series S000009239

Share classes and tickers: EXCAX (C000180000), TAFTX (C000025170), TECCX (C000025172), TECFX (C000025173), TEFEX (C000068592), TTCAX (C000189456)

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 2,442 with, 181 against, 0 abstentions (not counted as with management); 5 items carried no recommendation; 3 split votes are in neither count. Shareholder proposals: 43 FOR, 139 AGAINST, 0 abstained, by the filing’s own vote-source field.

Compared with Capital Group as a whole

The same two figures as Capital Group’s manager page (120,065 ballot items across 80 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsCapital GroupItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)98.9%2,32996.6%98,284
Backed environmental and social shareholder proposals at US companies1.1%941.3%2,130

Where this fund voted differently from most Capital Group funds

Each ballot item this fund voted is set against the votes of the other Capital Group funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted differently from most Capital Group funds on 4 items (0.2% of the 2,336 items where a comparison was possible).

The most lopsided family majorities first, then the largest companies, then shareholder proposals.
CompanyMeetingItemThis fundMost Capital Group fundsMgmtResult
Oracle Corporation2025-11-18Advisory Vote to Approve the Compensation of our Named Executive OfficersAgainstFOR — 15 of 23 Capital Group fundsAgainstPassed (calculated), 81.9% support
AstraZeneca PLC2026-04-09Authorise Issue of Equity without Pre-emptive RightsForAGAINST — 10 of 16 Capital Group fundsFor—
AstraZeneca PLC2026-04-09Authorise Issue of Equity without Pre-emptive Rights in Connection with an Acquisition or Other Capital InvestmentForAGAINST — 10 of 16 Capital Group fundsFor—
Berkshire Hathaway Inc.2026-05-02Shareholder Shareholder proposal requesting that the Company issue a report disclosing the Board's oversight framework for workforce and human-capital management across its operating subsidiaries.AgainstFOR — 4 of 5 Capital Group fundsFor—

Download all 4 differences (CSV)

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 90.4% of this fund’s 2,623 such votes could be given a sector; the other 252 (9.6%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Finance486265.3%
Consumer Discretionary437439.8%
Technology3434814.0%
Industrials300175.7%
Health Care221167.2%
Utilities17363.5%
Consumer Staples13286.1%
Real Estate11700.0%
Energy9155.5%
Basic Materials4012.5%
Telecommunications3139.7%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections1,8280
Audit-related1880
Corporate Governance18471
Say-on-Pay1680
Compensation936
Capital Structure600
Other Social Issues4240
Environment or Climate3838
Human Rights or Human Capital/workforce1414
Shareholder Rights and Defenses129

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
Broadcom Inc.April 20, 2026$768M100
Microsoft CorporationDecember 5, 2025$749M216
Apple Inc.February 24, 2026$402M121
Meta Platforms, Inc.May 27, 2026$332M229
Eli Lilly and CompanyMay 4, 2026$314M102
Philip Morris International Inc.May 6, 2026$270M131
Amgen Inc.May 19, 2026$254M151
Marsh & McLennan Companies, Inc.May 21, 2026$240M150

Notable votes against management

MeetingCompanyProposalFundMgmt
December 5, 2025Microsoft CorporationEuropean Security Program Censorship Risk Audit Shareholder proposalAgainstFor
December 5, 2025Microsoft CorporationReport on Risks of Censorship in Generative Artificial Intelligence Shareholder proposalAgainstFor
February 24, 2026Apple Inc.A shareholder proposal entitled "China Entanglement Audit" Shareholder proposalAgainstFor
May 27, 2026Meta Platforms, Inc.A shareholder proposal regarding report on Al data usage oversight. Shareholder proposalAgainstFor
May 27, 2026Meta Platforms, Inc.A shareholder proposal regarding annual vote regarding executive pay. Shareholder proposalForAgainst
May 4, 2026Eli Lilly and CompanyShareholder proposal to adopt a policy and amend the bylaws to require an independent board chair. Shareholder proposalForAgainst
May 4, 2026Eli Lilly and CompanyShareholder proposal to prepare an annual lobbying report. Shareholder proposalAgainstFor
May 6, 2026Philip Morris International Inc.Shareholder Proposal to issue a report on filter cleanup costs and extended producer responsibility laws for filters Shareholder proposalAgainstFor
May 19, 2026Amgen Inc.Stockholder proposal to require an independent board chairman. Shareholder proposalAgainstFor
June 1, 2026UnitedHealth Group IncorporatedIf properly presented at the 2026 Annual Meeting of Shareholders, the shareholder proposal requesting the adoption of a policy to require any Board Chair to be independent. Shareholder proposalAgainstFor
January 27, 2026Visa Inc.Shareholder proposal requesting the Board of Directors to adopt a policy for an independent chair. Shareholder proposalAgainstFor
January 27, 2026Visa Inc.Shareholder proposal on shareholder right to act by written consent. Shareholder proposalForAgainst

Funds that vote the same way

These funds reported the same votes as Tax-Exempt Fund of California in the latest season, so they share this page:

Search this fund’s votes by company

2,636 ballot items at 184 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, Tax-Exempt Fund of California (EXCAX) voted at 184 shareholder meetings of 180 companies, on 2,636 ballot items in all. Where management made a recommendation, the fund followed it on 93.1% of the items and voted against it 181 times. Its most frequent area of disagreement was corporate governance (71 of its votes against management). It voted FOR 23.6% of the 182 shareholder proposals on which it cast a FOR or AGAINST vote. It voted FOR the board's own proposals more often than Capital Group's funds as a whole (98.9% against 96.6%). It voted differently from most Capital Group funds on 4 items.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Capital Group’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.